BioPharmSignal logoBioPharmSignal

Biotech News

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Talphera Inc (TLPH)TalpheraCompany update

SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a virtual investor

Related news

TLPHTalphera2026-03-25 12:30 EST

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

TLPHTalphera2026-05-07 20:05 EST

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

View all latest news

Talphera Inc

Talphera is a specialty pharmaceutical company focused on acute-care and pain management products. Its story is centered on hospital-oriented therapies and the challenge of commercial execution in acute care.

Recent company news

TLPHTalphera2026-09-03 12:30 EST

Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

TLPHTalphera2026-08-12 20:05 EST

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

TLPHTalphera2026-08-05 20:05 EST

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

TLPHTalphera2026-05-13 20:05 EST

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

TLPHTalphera2026-05-07 20:05 EST

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

Stock data

Close
1.11 USD
Market cap
40.24M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States